APA aipamena

Li, S., Zhu, C., Zhou, X., Chen, L., Bo, X., Shen, Y., . . . Yue, W. (2022). Engineering ROS‐Responsive Bioscaffolds for Disrupting Myeloid Cell‐Driven Immunosuppressive Niche to Enhance PD‐L1 Blockade‐Based Postablative Immunotherapy. Wiley.

Chicago Style aipamena

Li, Shaoyue, et al. Engineering ROS‐Responsive Bioscaffolds for Disrupting Myeloid Cell‐Driven Immunosuppressive Niche to Enhance PD‐L1 Blockade‐Based Postablative Immunotherapy. Wiley, 2022.

MLA aipamena

Li, Shaoyue, et al. Engineering ROS‐Responsive Bioscaffolds for Disrupting Myeloid Cell‐Driven Immunosuppressive Niche to Enhance PD‐L1 Blockade‐Based Postablative Immunotherapy. Wiley, 2022.